Manhattan Scients Ownership

MHTX Stock  USD 0.0001  0.00  0.00%   
Manhattan Scients maintains a total of 559.28 Million outstanding shares. Manhattan Scients secures 18.63 % of its outstanding shares held by insiders and 0.3 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Manhattan Scients in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Manhattan Scients, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Manhattan Scients. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Manhattan Pink Sheet Ownership Analysis

About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Manhattan Scients had not issued any dividends in recent years. Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York. Manhattan Scients operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1 people.The quote for Manhattan Scients is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Manhattan Scients contact Emmanuel Tsoupanarias at 212 541 2405 or learn more at https://www.mhtx.com.

Manhattan Scients Outstanding Bonds

Manhattan Scients issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Manhattan Scients uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Manhattan bonds can be classified according to their maturity, which is the date when Manhattan Scients has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Manhattan Pink Sheet Analysis

When running Manhattan Scients' price analysis, check to measure Manhattan Scients' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Manhattan Scients is operating at the current time. Most of Manhattan Scients' value examination focuses on studying past and present price action to predict the probability of Manhattan Scients' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Manhattan Scients' price. Additionally, you may evaluate how the addition of Manhattan Scients to your portfolios can decrease your overall portfolio volatility.